Terry Van Dyke - Concepedia

Author

Terry Van Dyke

University of North Carolina at Chapel Hill

Also Known As

Agbandje-McKenna, Mavis, Baldwin, Albert S., Choi, Vivian, Difilippantonio, Simone, Funkhouser, William K., Gallant, Judith, Gao, Jingjin, Greenberg, Norman M, Krall, Leonard, Lin, Weili

308

Publications

12.2K

Citations

H-Index

143

Concepts

All Affiliations

University of North Carolina at Chapel Hill UNC Lineberger Comprehensive Cancer Center National Cancer Institute University of Pittsburgh Cancer Genetics (United States)

About

Terry Van Dyke is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	46	6.1K
2	Health Sciences	4	4	234
3	Natural Sciences	3	3	301
4	Public Health	2	2	56
5	Engineering	1	1	18

Terry Van Dyke

Publications

10.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Jason I. Herschkowitz, Karl Simin, Victor Weigman, Genome biology	2007	1.3K
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy Mara H. Sherman, Ruth T. Yu, Dannielle D. Engle, Cell Tumor BiologyPancreatic CancerMedicinePharmacologyGastroenterology	2014	1.1K
p53-Dependent apoptosis suppresses tumor growth and progression in vivo Holly Symonds, Leonard Krall, Lee Ann Remington, Cell Tumor BiologyMedicineApoptosisP53-dependent Apoptosis SuppressesCell Death	1994	880
Pten Dose Dictates Cancer Progression in the Prostate Lloyd C. Trotman, Masaru Niki, Zohar Dotan, PLoS Biology	2003	664
Bax suppresses tumorigenesis and stimulates apoptosis in vivo Chaoying Yin, C. Michael Knudson, Stanley J. Korsmeyer, Nature ApoptosisCell DeathAnti-cancer AgentMedicineCell Biology	1997	662
Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma, Cancer Discovery	2013	622
Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors Ralph L. Brinster, Howard Y. Chen, Albee Messing, Cell Knockout MouseNeuro-oncologyImmunogeneticsTransgenic Mouse ModelsMedicine	1984	489
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis Reginald Hill, Yurong Song, Robert D. Cardiff, Cell Tumor BiologyEpithelial-mesenchymal TransitionDevelopmental BiologyP53 LossMedicine	2005	322
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles Wuping Li, Aravind Asokan, Zhijian Wu, Molecular Therapy	2008	258
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Hua Wu, Mark Wade, Leonard Krall, Genes & Development	1996	233

Page 1